These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27614782)

  • 1. Vaccine purchasing groups in the United States: An overview of their policies and practices.
    Cowan AE; Clark SJ; Gordon JL; Bok K; Shen AK
    Vaccine; 2016 Sep; 34(42):5060-5065. PubMed ID: 27614782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2009 Dec; 124 Suppl 5():S459-65. PubMed ID: 19948577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine financing and billing in practices serving adult patients: A follow-up survey.
    Lindley MC; Hurley LP; Beaty BL; Allison MA; Crane LA; Brtnikova M; Snow M; Bridges CB; Kempe A
    Vaccine; 2018 Feb; 36(8):1093-1100. PubMed ID: 29366706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines].
    Barth J; Hammerschmidt T; Vollmar J; Bierbaum M; Schöffski O
    Gesundheitswesen; 2014 Apr; 76(4):e7-e13. PubMed ID: 24081570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financing of Vaccine Delivery in Primary Care Practices.
    Allison MA; O'Leary ST; Lindley MC; Crane LA; Hurley LP; Beaty BL; Brtnikova M; Jimenez-Zambrano A; Babbel C; Berman S; Kempe A
    Acad Pediatr; 2017; 17(7):770-777. PubMed ID: 28600199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do generics offer significant savings to the UK National Health Service?
    Kanavos P
    Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
    Hernandez I; San-Juan-Rodriguez A; Good CB; Gellad WF
    JAMA; 2020 Mar; 323(9):854-862. PubMed ID: 32125403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
    Mattingly TJ; Levy JF; Slejko JF; Onwudiwe NC; Perfetto EM
    Pharmacoeconomics; 2018 Sep; 36(9):1093-1099. PubMed ID: 29752675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytics for vaccine economics and pricing: insights and observations.
    Robbins MJ; Jacobson SH
    Expert Rev Vaccines; 2015 Apr; 14(4):605-16. PubMed ID: 25435003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Net financial gain or loss from vaccination in pediatric medical practices.
    Coleman MS; Lindley MC; Ekong J; Rodewald L
    Pediatrics; 2009 Dec; 124 Suppl 5():S472-91. PubMed ID: 19948579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing prices offered to pharmaceutical purchasing groups.
    Raehtz TR; Milewski R; Massoud N
    Am J Hosp Pharm; 1987 Sep; 44(9):2073-6. PubMed ID: 3674046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size of clinical trials and Introductory prices of prophylactic vaccine series.
    Weinberg SH; Butchart AT; Davis MM
    Hum Vaccin Immunother; 2012 Aug; 8(8):1066-70. PubMed ID: 22854668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments.
    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2005 Jan; 70(15):3490-3. PubMed ID: 15669145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the pricing of childhood vaccines in the U.S. public sector.
    Chen W; Messonnier M; Zhou F
    Health Econ; 2018 Feb; 27(2):252-265. PubMed ID: 28660666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.